DHL Group:
DHL Health Logistics
DHL Group is the world’s leading logistics company, connecting people and markets and facilitating global trade.
The Group is organised into five operating divisions:
-
Express
Transportation of urgent documents and goods reliably and on time from door to door.
-
Global Forwarding, Freight
International air and ocean freight as well as European overland transportation services.
-
Supply Chain
Standardised warehousing, transport and value-added services that can be combined to form customised supply chain solutions.
-
eCommerce
The core business is domestic parcel transport in selected countries in Europe, in the United States, in certain countries in Asia, in particular in India, and deferred cross-border services.
-
Post & Parcel Germany
A broad spectrum of mail and parcel services.
DHL aims to be the preferred choice for customers, employees, investors, and green logistics around the world. As part of its 2030 strategy, “Accelerate Sustainable Growth,” DHL Group is focusing on promoting sustainable growth within its core logistics businesses and expanding its group growth initiatives.
This includes strengthening its Life Science and Healthcare logistics services within the DHL Supply Chain Pharma Specialised Network (PSN), specifically under the DHL Health Logistics sector brand.
Life Science and Healthcare
The Life Sciences and Healthcare sector is experiencing a profound transformation, driven by increasing supply chain complexities, the demand for smaller and colder shipments, and the rise of personalized medicine. At DHL, we are fully committed to supporting our customers through this transition capitalizing on the resulting growth opportunities. By leveraging our specialized capabilities and integrated approach, we are intensifying our investments in new capabilities where required to stay ahead of industry trends, delivering substantial value to the sector, and double the Group’s Life Sciences and Healthcare revenue by 2030.
OSCAR DE BOK, CEO DHL SUPPLY CHAIN,GROUP SPONSOR LSH INITIATIVE
The Life Sciences and Healthcare (LSH) sector is increasingly focused on advanced treatments, such as biopharmaceuticals and innovative therapies like cell and gene therapy. These treatments require specialised supply chain services, including temperature-controlled logistics for air, ocean, and road transport, direct delivery to patients or hospitals, and comprehensive integrated solutions for clinical trials and biopharmaceuticals.